Shares of Day One Biopharmaceuticals, Inc. (DAWN) are surging about 65 percent on Friday morning trading after Servier, an independent international pharmaceutical group, agreed to acquire the company for $21.50 per share in cash.
The company's shares are currently trading at $21.15 on the Nasdaq, up 65.49 percent. The stock opened at $21.12 and has climbed as high as $21.19 so far in today's session. Over the past year, it has traded in a range of $5.64 to $21.19.
Day One expects the acquisition to represent a unique opportunity to extend the reach of its science and its lead program in pediatric low-grade glioma. The deal is estimated to be completed in the second quarter of 2026.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.